0001894897-21-000001.txt : 20211122
0001894897-21-000001.hdr.sgml : 20211122
20211122153921
ACCESSION NUMBER: 0001894897-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211122
DATE AS OF CHANGE: 20211122
EFFECTIVENESS DATE: 20211122
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexosome Oncology Holdings, Inc.
CENTRAL INDEX KEY: 0001894897
IRS NUMBER: 873247597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-422096
FILM NUMBER: 211432301
BUSINESS ADDRESS:
STREET 1: 8700 CORPORATE DRIVE
STREET 2: SUITE 403
CITY: LEXINGTON
STATE: KY
ZIP: 40503
BUSINESS PHONE: (301) 502-3655
MAIL ADDRESS:
STREET 1: 8700 CORPORATE DRIVE
STREET 2: SUITE 403
CITY: LEXINGTON
STATE: KY
ZIP: 40503
D
1
primary_doc.xml
X0708
D
LIVE
0001894897
Nexosome Oncology Holdings, Inc.
8700 CORPORATE DRIVE
SUITE 403
LEXINGTON
KY
KENTUCKY
40503
(301) 502-3655
DELAWARE
None
None
Corporation
true
2021
Todd
Hembrough
8700 Corporate Drive
Suite 403
Lexington
KY
KENTUCKY
40503
Executive Officer
Director
Brian
Brohman
8700 Corporate Drive
Suite 403
Lexington
KY
KENTUCKY
40503
Director
Alan
Ezrin
8700 Corporate Drive
Suite 403
Lexington
KY
KENTUCKY
40503
Director
Robert
Saunders
8700 Corporate Drive
Suite 403
Lexington
KY
KENTUCKY
40503
Director
Matthew
Dicken
8700 Corporate Drive
Suite 403
Lexington
KY
KENTUCKY
40503
Director
Other Health Care
Decline to Disclose
- 06b
false
2021-11-05
false
true
false
0
4000000
3652126
347874
Total amount sold includes conversion of equity participation agreements.
false
48
0
0
0
false
Nexosome Oncology Holdings, Inc.
/s/ Todd Hembrough
Todd Hembrough
Chief Executive Officer
2021-11-22